OMED

OncoMed Pharmaceuticals, Inc.

OMED

Delisted

OMED was delisted on the 22nd of April, 2019.

41 hedge funds and large institutions have $16.9M invested in OncoMed Pharmaceuticals, Inc. in 2019 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 7 closing their positions.

2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1 2016 Q4 2016 Q3 2016 Q2 2016 Q1 2015 Q4 2015 Q3 2015 Q2 2015 Q1 2014 Q4 2014 Q3 2014 Q2 2014 Q1 2013 Q4 2013 Q3

Holders

Holders Change

-1

Holders Change %

-2.38%

% of All Funds

0.89%

Holding in Top 10

–

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

–

New

Increased

Reduced

Closed

Calls

–

Puts

–

Net Calls

–

Net Calls Change

–

Top Buyers

1	1 Renaissance Technologies New York	$1.88M
2	BC 2 Birchview Capital Burlington, Vermont	$387K
3	3 Deutsche Bank Frankfurt Am Main Ge, Germany	$137K
4	AP 4 Appleton Partners Boston, Massachusetts	$69K
5	QOP 5 Quinn Opportunity Partners Charlottesville, Virginia	$69K

Top Sellers

1	HP 1 Harbourvest Partners Boston, Massachusetts	$0
2	2 Jacobs Levy Equity Management Florham Park, New Jersey	$0
3	3 D.E. Shaw & Co New York	$88K
4	4 Dimensional Fund Advisors Austin, Texas	$0
5	5 Primecap Management Pasadena, California	$5.67M

#	Name	Market Value	Shares	Shares Change	Shares Change %
1	1 Primecap Management Pasadena, California	$5.67M	5,451,400	-54,900	-1%
2	BI 2 BVF Inc San Francisco, California	$4.27M	4,108,815	+65,826	+2%
3	3 Renaissance Technologies New York	$1.88M	1,809,489	+590,882	+48%
4	PA 4 Perceptive Advisors New York	$1.79M	1,719,111	–	–
5	CS 5 Candriam SCA Strassen, Luxembourg, Luxembourg	$395K	380,000	–	–
6	BC 6 Birchview Capital Burlington, Vermont	$387K	372,557	+200,000	+116%
7	7 Vanguard Group Malvern, Pennsylvania	$369K	355,162	-132	-0%
8	CC 8 Cannell & Co New York	$293K	281,983	-21,088	-7%
9	9 Acadian Asset Management Boston, Massachusetts	$252K	241,507	+46,400	+24%
10	10 BlackRock New York	$245K	235,879	+8,242	+4%
11	11 Geode Capital Management Boston, Massachusetts	$205K	197,855	+24,292	+14%
12	12 Norges Bank Oslo, Norway	$190K	182,357	–	–
13	13 Deutsche Bank Frankfurt Am Main Ge, Germany	$137K	132,597	+77,897	+142%
14	SIM 14 Spark Investment Management New York	$95K	91,400	–	–
15	15 D.E. Shaw & Co New York	$88K	84,433	-71,816	-46%
16	16 Bank of America Charlotte, North Carolina	$87K	83,826	–	–
17	BCM 17 Bridgeway Capital Management Houston, Texas	$84K	80,900	-50,000	-38%
18	PAM 18 Panagora Asset Management Boston, Massachusetts	$69K	65,937	+11,434	+21%
19	QOP 19 Quinn Opportunity Partners Charlottesville, Virginia	$69K	66,162	+66,162	New
20	AP 20 Appleton Partners Boston, Massachusetts	$69K	66,206	+66,206	New
21	21 Northern Trust Chicago, Illinois	$60K	58,048	–	–
22	NSEDCP 22 NJ State Employees Deferred Compensation Plan Trenton, New Jersey	$40K	38,000	–	–
23	23 Tudor Investment Corp Stamford, Connecticut	$33K	31,909	–	–
24	FM 24 Fondren Management Houston, Texas	$26K	25,136	+25,136	New
25	25 Bank of New York Mellon New York	$24K	22,977	-561	-2%

OncoMed Pharmaceuticals, Inc. OMED

Top Buyers

Top Sellers

OncoMed Pharmaceuticals, Inc.

OMED